机译:糖皮质激素促进乳腺癌转移
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland|Wellmera AG Basel Switzerland;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland;
Univ Helsinki Div Pharmaceut Chem & Technol Fac Pharm Helsinki Finland|UCB Celltech Dev Sci Slough Berks England;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland|Novartis Inst BioMed Res Basel Switzerland;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland|Swiss Inst Bioinformat Basel Switzerland;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland;
Univ Basel Inst Pathol Univ Basel Hosp Basel Switzerland;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland;
Friedrich Miescher Inst Biomed Res Basel Switzerland;
Univ Basel Prote Core Facil Biozentrum Basel Switzerland;
Univ Basel Dept Biomed Dept Surg Univ Basel Hosp Basel Switzerland|Friedrich Miescher Inst Biomed Res Basel Switzerland;
机译:血清和糖皮质激素诱导的激酶1对于骨质细胞发生并促进乳腺癌骨转移至关重要
机译:糖皮质激素促进乳腺癌转移
机译:糖皮质激素受体活性促进乳腺癌转移
机译:在乳腺癌中骨髓微转移作为骨髓微转移的标记的硅和体外分析
机译:癌细胞与肿瘤微环境之间的相互交流促进乳腺癌转移
机译:糖皮质激素受体–IRS-1轴控制EMT和乳腺癌的转移
机译:朋友白血病病毒整合1是乳腺癌预后不良的预测因子,促进乳腺癌细胞的转移和癌症干细胞性质